
Find clinical insights across hundreds of oncology topics.
Loading recent podcasts…
Tumor Board Episode #50
Mar 10, 2026
with Dr. Ryan Funk, Dr. Dustin Boothe
Though relatively new, there is a rapidly growing interest in the field of therapeutic radiopharmaceuticals and their...
Tumor Board Episode #48
Feb 17, 2026
with Dr. Erika Hamilton, Dr. Lindsay Peterson
In a patient with metastatic HER2-positive breast cancer, what should guide the next decision: trial data, toxicity, or...
110+ listens
Tumor Board Episode #46
Feb 3, 2026
with Dr. William Moore, Dr. Daniel Sterman, Dr. Ben Cooper
Pulsed electric field (PEF) therapy is an emerging cancer treatment that utilizes short electrical pulses to disrupt...
260+ listens
Tumor Board Episode #44
Jan 20, 2026
with Dr. Jonathan Mizrahi, Dr. Jun Gong
The FLOT regimen is the standard-of-care for upper gastroesophageal malignancies, but what if there were other drug...
90+ listens
Tumor Board Episode #49
Feb 24, 2026
with Dr. Bora Lim, Dr. Lindsay Peterson
Inflammatory breast cancer (IBC) is rare but highly aggressive, and often hides in plain sight. Rather than presenting...
70+ listens
Tumor Board Episode #47
Feb 10, 2026
with Dr. Wade Iams, Dr. Kate Baker
Bispecific antibodies are emerging as an important therapeutic class in non-small cell lung cancer (NSCLC); but how do...
170+ listens
Tumor Board Episode #45
Jan 27, 2026
with Dr. Amanda Nizam, Dr. Brad McGregor, Dr. Alan Tan
Is the era of cisplatin over, or are we simply becoming more precise about who benefits from it? As perioperative...
1,200+ listens
Tumor Board Episode #43
Jan 13, 2026
with Dr. Jun Gong, Dr. Jonathan Mizrahi
Get caught up on the cutting edge colorectal cancer trial data from ESMO 2025 with this 30-minute BackTable Tumor Board...
170+ listens
Tumor Board Case
Nov 11, 2025
with Dr. Scott Genshaft, Dr. Karen Reckamp, Dr. Scott Atay, Dr. Scott Oh and Dr. Alan Lee
Tumor Board Case
Nov 11, 2025
with Dr. Alan Lee, Dr. Scott Oh, Dr. Robert Suh, Dr. Scott Genshaft and Dr. Venkatesh Krishnasamy
Tumor Board Case
Nov 11, 2025
with Dr. Venkatesh Krishnasamy, Dr. Scott Atay, Dr. Scott Genshaft and Dr. Scott Oh
Tumor Board Case
Jan 22, 2025
with Dr. Gabriel Schnickel, Dr. Adam Burgoyne, Dr. Heather Patton, Dr. Siddharth Padia and Dr. Zach Berman
Tumor Board Case
Nov 11, 2025
with Dr. Alan Lee, Dr. Scott Oh, Dr. Robert Suh, Dr. Scott Genshaft and Dr. Venkatesh Krishnasamy
Tumor Board Case
Nov 11, 2025
with Dr. Venkatesh Krishnasamy, Dr. Scott Atay, Dr. Scott Genshaft and Dr. Scott Oh
Tumor Board Case
Jan 22, 2025
with Dr. Gabriel Schnickel, Dr. Adam Burgoyne, Dr. Heather Patton, Dr. Siddharth Padia and Dr. Zach Berman
Tumor Board Case
Jan 22, 2025
with Dr. Gabriel Schnickel, Dr. Adam Burgoyne, Dr. Heather Patton, Dr. Siddharth Padia and Dr. Zach Berman
Tumor Board Course
2 CME/CE credits, 2.5 hours, 26 lessons
Tumor Board Course
2 CME/CE credits, 2 hours, 20 lessons
Tumor Board Course
2 CME/CE credits, 2 hours, 22 lessons
Tumor Board Course
2 CME/CE credits, 2.5 hours, 19 lessons

Treatment of hepatocellular carcinoma (HCC), like that of many other cancers, spans a spectrum from curative to...
Tumor Board
Episode # 5 • 17 Jan 2025
Complex HCC Patients & The "Grey Zone": What To Do When You Don’t Know What To Do
with Dr. Adam Burgoyne, Dr. Zach Berman, Dr. Kirema Garcia-Reyes, Dr. Lingling Du, Dr. Sabeen Dhand
BackTable Tumor Board Podcast
50 Podcasts • 14 Cases • 5 Courses • Updated Weekly
For healthcare professionals that play an active role in cancer care, including medical oncologist, surgical oncologists, radiation oncologists, and surgical subspecialists. Follow this show on the BackTable app to get notified when new episodes drop.
The Materials available on BackTable are provided for informational and educational purposes only and are not a substitute for the independent professional judgment of a qualified healthcare professional in diagnosing or treating patients. Any opinions, statements, or views expressed are those of the individual contributors and do not necessarily reflect those of the publisher, platform, or any affiliated organization.











